Track Insider Trading in Facebook, Zynga, Arena Pharmaceuticals, Lululemon Athletica, Weatherford International, and Bank of America



Insiderslab.com is has released insider trading report for US market investors to track the performance of company insiders, which can help the portfolios. Today’s report will cover the following stocks: Facebook (NASDAQ:FB), Zynga (NASDAQ:ZNGA), Arena Pharmaceuticals (NASDAQ:ARNA), Lululemon Athletica (NASDAQ:LULU), Weatherford International (NYSE:WFT), and Bank of America (NYSE:BAC).
 
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
 
Report Highlights:
 
Facebook Inc (NASDAQ:FB)): By the end of last trading session, the shares of Facebook (NASDAQ:FB) lost US$0.29 (or 0.64%) to US$44.75 with 68.05 million shares exchanged hands, compared to daily average volume of 65.38 million. Insiderslab.com found company VP Marketing & Bus. Part., David B. Fischer, sold his shares at the price of US$43.38 on September 11. One day before, the company Chief Operating Officer, Sheryl Sandberg, sold her shares at the price of US$43.69, which was part of her US$123.10 million selling within last three months. Investors may want to find out how Facebook insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for FB here.
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/FB/Facebook.pdf
 
Zynga Inc (NASDAQ:ZNGA): By the end of last trading session, Zynga (NASDAQ:ZNGA) shares earned 0.67% to US$3.02 with about 14.74 million shares exchanged hands for the session, compared to its average volume of 15.65 million shares. Insiderslab.com found company Directors, Stanley J. Meresman and Jeffrey Katzenberg, sold their shares at the price of US$2.86 on September 3. Investors may want to find out how Zynga insiders like CEOs, CFOs and Directors are thinking about the future of the company.
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/ZNGA/Zynga.pdf
 
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): By the end of last trading session, Arena Pharmaceuticals (NASDAQ:ARNA) dropped 2.57% to US$5.87 with about 9.45 million shares exchanged hands for the session, compared to its average volume of 4.61 million shares. Insiderslab.com found company EVP & Chief Scientific Officer, Dominic P. Behan, sold his shares at the price of US$6.31 for about US$1.26 million on September 10. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in Arena are starting to sell more company shares. See insider trade report for ARNA here.
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/ARNA/Arena.pdf
 
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
 
Lululemon Athletica inc. (NASDAQ:LULU):
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/LULU/LululemonAthletica.pdf
 
Weatherford International Ltd (NYSE:WFT):
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/WFT/Weatherford.pdf
 
Bank of America Corp (NYSE:BAC):
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/BAC/BankofAmerica.pdf
 
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
 
About Insiderslab.com:
 
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
 
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
Source:
www.insiderslab.com
www.insiderslab.com

Reported on Sep 13, 2013

 
More Insider News ...

Today's Notable Trades


CERNER CORP /MO/ (CERN)
Senior Officer (Exec VP & COO): Nill Michael

Acquired 50,000 Common Stock (Non-Derivative security at $13.653) on Oct 28, 2014. Direct holding 183,006 shares/units after transaction. Holdings increased 37.59%.
Filing date: Oct 29, 2014. Record updated at 11:16:53.
 
BOSTON BEER CO INC (SAM)
First-Class Insider (President and C.E.O.): ROPER MARTIN F

Sold 1,937 Class A Common (Non-Derivative security at $224.960) on Oct 28, 2014. Direct holding 3,674 shares/units after transaction. Holdings decreased -34.52%.
Filing date: Oct 29, 2014. Record updated at 11:16:52.
 
CABOT OIL & GAS CORP (COG)
Director: PEACOCK P DEXTER

Sold 50,000 Common Stock (Non-Derivative security at $30.888) on Oct 28, 2014. Direct holding 257,745 shares/units after transaction. Holdings decreased -16.25%.
Filing date: Oct 29, 2014. Record updated at 11:16:51.
 
CHUBB CORP (CB)
Senior Officer (Executive Vice President): Robusto Dino

Sold 18,790 Common Shares (Non-Derivative security at $97.679) on Oct 27, 2014. Direct holding 41,348 shares/units after transaction. Holdings decreased -31.24%.
Filing date: Oct 29, 2014. Record updated at 11:16:49.
 
UNITY BANCORP INC /NJ/ (UNTY)
Senior Officer (Chief Financial Officer): BEDNER ALAN J

Sold 15,000 Stock Option (Derivative security at conversion or exercise price: $3.980) on Oct 29, 2014. Direct holding 45,068 shares/units after transaction. Stock Option expires on Dec 10, 19. Holdings decreased -24.97%.
Filing date: Oct 29, 2014. Record updated at 11:16:49.
 
UNITED AMERICAN HEALTHCARE CORP (UAHC)
10% shareholder: Dove Foundation

Acquired 2,000,000 Common Stock (Non-Derivative security at $0.004) on Oct 24, 2014. Direct holding 4,478,647 shares/units after transaction. Holdings increased 80.69%.
Filing date: Oct 29, 2014. Record updated at 11:16:46.
 
Stone Harbor Emerging Markets Total Income Fund (EDI)
Senior Officer (Executive Vice President): CRAIGE JAMES E

Acquired 8,565 Common Shares of Beneficial Interest (Non-Derivative security at $18.083) on Oct 29, 2014. Direct holding 16,216 shares/units after transaction. Holdings increased 111.95%.
Filing date: Oct 29, 2014. Record updated at 11:16:31.
 
V F CORP (VFC)
First-Class Insider (Chairman, President & CEO): WISEMAN ERIC C

Acquired 229,800 Common Stock (Non-Derivative security at $19.880) on Oct 28, 2014. Direct holding 773,120 shares/units after transaction. Holdings increased 42.30%.
Filing date: Oct 29, 2014. Record updated at 11:16:31.
 
HNI CORP (HNI)
Senior Officer (Executive Vice President): DITTMER JERALD K

Acquired 9,200 Common Stock (Non-Derivative security at $42.660) on Oct 28, 2014. Direct holding 26,774 shares/units after transaction. Holdings increased 52.35%.
Filing date: Oct 29, 2014. Record updated at 11:16:30.
 
GABELLI EQUITY TRUST INC (GAB)
Director: CONN JAMES P

Acquired 8,378 Common Stock, Par Value $0.001 (Non-Derivative security at $5.750) on Oct 27, 2014. Direct holding 67,024 shares/units after transaction. Holdings increased 14.29%.
Filing date: Oct 29, 2014. Record updated at 11:16:23.
 
Read more

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.